Immuneering CorporationIMRXNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-63.69M
↓ 65% below average
Average (5y)
$-38.55M
Historical baseline
Range
High:$-7.34M
Low:$-63.69M
CAGR
+54.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-63.69M | -9.7% |
| 2023 | $-58.06M | -12.8% |
| 2022 | $-51.47M | -52.6% |
| 2021 | $-33.73M | -98.4% |
| 2020 | $-17.00M | -131.7% |
| 2019 | $-7.34M | - |